Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Second Life Therapeutics
Novartis
University of Sunderland
University of Sunderland
Hoffmann-La Roche